Next generation plasma proteome profiling to monitor health and disease
The proximity extension assay (PEA) is a popular tool to measure plasma protein levels. Here, the authors extend the proteome coverage of PEA by combining it with next-generation sequencing, enabling the analysis of nearly 1500 proteins from minute amounts of plasma.
Main Authors: | Wen Zhong, Fredrik Edfors, Anders Gummesson, Göran Bergström, Linn Fagerberg, Mathias Uhlén |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-22767-z |
Similar Items
-
Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms
by: Wen Zhong, et al.
Published: (2021-12-01) -
Longitudinal plasma protein profiling of newly diagnosed type 2 diabetes
by: Anders Gummesson, et al.
Published: (2021-01-01) -
Whole-genome sequence association analysis of blood proteins in a longitudinal wellness cohort
by: Wen Zhong, et al.
Published: (2020-06-01) -
Absolute Quantification of Pan-Cancer Plasma Proteomes Reveals Unique Signature in Multiple Myeloma
by: David Kotol, et al.
Published: (2023-09-01) -
Next generation pan-cancer blood proteome profiling using proximity extension assay
by: María Bueno Álvez, et al.
Published: (2023-07-01)